The Function Improved of the Newly Designed Magnetic-End Ureteric Stenting Retrieval Device: A Clinical Prospective Randomized and Control Trial in a Multicenter Study

Table 2

Results of the USSQ scores between two groups.

	Postoperative 1 week			Postoperative 3 week
	Group A	Group B	Pvalue	Group A	Group B	P value
USSQ total scores (mean ± SD)	85.7 (±9.9)	76.5 (±10.3)	0.351	83.1 (±9.4)	71.6 (±11.8)	0.287
Urinary symptoms (mean ± SD)	30.5 (±7.5)	28.6 (±7.8)	0.556	29.6 (±8.5)	25.4 (±7.3)	0.344
Body pain (mean ± SD)	17.4 (±8.4)	16.8 (±9.1)	0.552	16.1 (±7.1)	15.6 (±6.2)	0.763
General health (mean ± SD)	18.9 (±7.8)	14.4 (±9.1)	0.254	17.4 (±6.5)	13.3 (±5.3)	0.819
Work performance (mean ± SD)	8.9 (±3.1)	7.8 (±.8)	0.845	10.7 (±3.9)	9.1(±4.5)	0.841
Sexual matters (mean ± SD)	9.9 (±2.3)	8.6 (±3.8)	0.709	9.4 (±3.3)	8.2 (±2.5)	0.769

Comparisons of the USSQ scores between two groups at 1 and 3 weeks postoperative follow-up.